This medication is a hormone, prescribed for secretion stimulating test in stimulation of pancreatic secretions, stimulation of gastrin secretion in order to identify gastrinoma, pancreatitis or pancreatic cancer. It inhibits gastric acid secretion.
Category: IN VIVO DIAGNOSTIC BIOLOGICALS
Drug Classification
METYRAPONE
METYRAPONE is a Schedule H drug.